Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

Edward Curry; Ian Green; Nadine Chapman-Rothe; Elham Shamsaei; Sarah Kandil; Fanny L. Cherblanc; Luke Payne; Emma Bell; Thota Ganesh; Nitipol Srimongkolpithak; Joachim Caron; Fengling Li; Anthony G. Uren; James P. Snyder; Masoud Vedadi; Matthew J. Fuchter; Robert Brown

doi:10.1186/s13148-015-0118-9

Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

Edward Curry, Ian Green, Nadine Chapman-Rothe, Elham Shamsaei, Sarah Kandil, Fanny L. Cherblanc, Luke Payne, Emma Bell, Thota Ganesh, Nitipol Srimongkolpithak, Joachim Caron, Fengling Li, Anthony G. Uren, James P. Snyder, Masoud Vedadi, Matthew J. Fuchter, Robert Brown^*

^*Corresponding author for this work

School of Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Number of pages	0
Journal	Clinical Epigenetics
Volume	7
Issue number	1
Early online date	21 Aug 2015
DOIs	https://doi.org/10.1186/s13148-015-0118-9
Publication status	Published - Dec 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13148-015-0118-9

Cite this

Curry, E., Green, I., Chapman-Rothe, N., Shamsaei, E., Kandil, S., Cherblanc, F. L., Payne, L., Bell, E., Ganesh, T., Srimongkolpithak, N., Caron, J., Li, F., Uren, A. G., Snyder, J. P., Vedadi, M., Fuchter, M. J., & Brown, R. (2015). Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells. Clinical Epigenetics, 7(1). https://doi.org/10.1186/s13148-015-0118-9

@article{9fd57ac0572e41009f6ec47b00a6611d,

title = "Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells",

author = "Edward Curry and Ian Green and Nadine Chapman-Rothe and Elham Shamsaei and Sarah Kandil and Cherblanc, {Fanny L.} and Luke Payne and Emma Bell and Thota Ganesh and Nitipol Srimongkolpithak and Joachim Caron and Fengling Li and Uren, {Anthony G.} and Snyder, {James P.} and Masoud Vedadi and Fuchter, {Matthew J.} and Robert Brown",

year = "2015",

month = dec,

doi = "10.1186/s13148-015-0118-9",

language = "English",

volume = "7",

journal = "Clinical Epigenetics",

issn = "1868-7075",

publisher = "BioMed Central Ltd.",

number = "1",

}

Curry, E, Green, I, Chapman-Rothe, N, Shamsaei, E, Kandil, S, Cherblanc, FL, Payne, L, Bell, E, Ganesh, T, Srimongkolpithak, N, Caron, J, Li, F, Uren, AG, Snyder, JP, Vedadi, M, Fuchter, MJ & Brown, R 2015, 'Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells', Clinical Epigenetics, vol. 7, no. 1. https://doi.org/10.1186/s13148-015-0118-9

TY - JOUR

T1 - Dual EZH2 and EHMT2 histone methyltransferase inhibition increases biological efficacy in breast cancer cells

AU - Curry, Edward

AU - Green, Ian

AU - Chapman-Rothe, Nadine

AU - Shamsaei, Elham

AU - Kandil, Sarah

AU - Cherblanc, Fanny L.

AU - Payne, Luke

AU - Bell, Emma

AU - Ganesh, Thota

AU - Srimongkolpithak, Nitipol

AU - Caron, Joachim

AU - Li, Fengling

AU - Uren, Anthony G.

AU - Snyder, James P.

AU - Vedadi, Masoud

AU - Fuchter, Matthew J.

AU - Brown, Robert

PY - 2015/12

Y1 - 2015/12

U2 - 10.1186/s13148-015-0118-9

DO - 10.1186/s13148-015-0118-9

M3 - Article

SN - 1868-7075

VL - 7

JO - Clinical Epigenetics

JF - Clinical Epigenetics

IS - 1

ER -